Atopic Dermatitis Drugs Market by Development Status, Competition Analysis, Type and Application 2027
Atopic
Dermatitis Drugs Market Overview
Atopic dermatitis most commonly affects children
and infants, and studies show that in recent years, one of the major causes for
its prevalence is air pollution.
According to a report published by Market Research
Future (MRFR), the global atopic dermatitis drugs market has been assessed to witness remarkable growth at
an 8.2% CAGR over the forecast period of 2017 to 2023.`
The global atopic dermatitis market is primarily
driven by the growing prevalence of atopic dermatitis, the increasing incidence
of food allergies, and the rising level of air pollution.
Request Free
Sample Copy at:
https://www.marketresearchfuture.com/sample_request/1610
Atopic
Dermatitis Drugs Market Segmentation
The global
atopic dermatitis market has been segmented on the basis of type, application,
end-user, and region.
Based on type,
it is segmented into calcitonin, erythropoietin, hormone, interferon,
monoclonal antibodies, and others.
Based on
application, the atopic dermatitis market is segmented into blood disorders,
cancer, chronic diseases, infectious diseases, and others.
Based on
end-users, it is segmented into clinics, hospitals, and research centers.
Atopic
Dermatitis Drugs Market Regional Analysis
North America
is the dominant region in the global atopic dermatitis market and has been
assessed to lead the market over the forecast period, owing to the extensive investment
in the healthcare sector, government expenditure towards healthcare research
and development for advancement, growing usage of cosmetics and perfumes which
lead to skin irritation, and the increasing patient population.
Europe has been
accounted for the second largest market share in the global atopic dermatitis
market. The market has been assessed to grow significantly due to the
increasing expenditure in stable economies such as France and Germany on
healthcare and ensures the affordability of high-quality medical care by consumers owing
to their steady disposable income.
The Asia
Pacific has been assessed as the fastest growing region in the global atopic
dermatitis market, owing to the increasing healthcare expenditure by the
governments in emerging economies such as China, and India, to provide
consumers with better medical facilities.
The Middle East
and Africa region has been assessed to show slow and gradual growth over the
forecast period and is expected to register the comparatively smallest market
share owing to the underdeveloped healthcare sector in the region and the
unstable economies.
Atopic
Dermatitis Drugs Market Players
·
Globus Medical, Inc. (U.S.)
·
Depuy Synthes Inc. (Johnson & Johnson) (U.S.)
·
Smith & Nephew plc. (UK)
·
NuVasive, Inc. (U.S.)
·
Stryker Corporation (U.S.)
·
Integra LifeSciences Holdings Corporation (U.S.)
·
Zimmer Biomet Holdings, Inc. (U.S.)
·
Medtronic, plc (Ireland)
·
Wright Medical Group N.V. (Netherlands)
·
The Orthopedic Implant Company (U.S.)
·
Aesculap Implant Systems (U.S.)
·
Conmed Corporation (U.S.)
·
BioTek Instruments, Inc. (U.S.)
·
Arthrocare Corporation (U.S.)
among others
are some key companies in the global atopic dermatitis that are listed by MRFR
for market research.
Browse Detailed
TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/atopic-dermatitis-market-1610
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private
Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment